tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market
CHRS
Coherus Biosciences
Overview
Analyst Forecasts
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding CHRS?
Track your performance easily
Link Broker

Coherus Biosciences (CHRS) Stock News & Sentiment

1,537 Followers
Coherus Biosciences Announces UDENYCA Divestiture and Revenue Outlook
Premium
Company Announcements
Coherus Biosciences Announces UDENYCA Divestiture and Revenue Outlook
18d ago
8K
CHRS
Coherus Biosciences Announces Board Member Resignation
Premium
Company Announcements
Coherus Biosciences Announces Board Member Resignation
2M ago
8K
CHRS
Coherus Biosciences Sells UDENYCA Franchise to Intas
Premium
Company Announcements
Coherus Biosciences Sells UDENYCA Franchise to Intas
2M ago
8K
CHRS
Coherus BioSciences Reports Strong Q3 2024 Growth
Premium
Company Announcements
Coherus BioSciences Reports Strong Q3 2024 Growth
3M ago
CHRS
Coherus Biosciences (CHRS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Coherus Biosciences (CHRS) Q3 Earnings Cheat Sheet
3M ago
CHRS
Coherus Biosciences Manages UDENYCA Supply Interruption and Cost Reductions
Premium
Company Announcements
Coherus Biosciences Manages UDENYCA Supply Interruption and Cost Reductions
5M ago
8K
CHRS
Coherus Biosciences Appoints Bryan McMichael as CFO
Premium
Company Announcements
Coherus Biosciences Appoints Bryan McMichael as CFO
6M ago
8K
CHRS
More CHRS News >

CHRS News on the Web

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down
Zacks
Neutral
Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Yahoo Finance
Neutral
Coherus Biosciences (CHRS) Receives a Buy from Truist Financial
TipRanks News
Bullish
Coherus Biosciences Announces Board Member Resignation
TipRanks News
Neutral
Coherus, sharpening immuno-oncology focus, sells another biosimilar for over $500M
BioPharma Dive
Neutral
Here's Why You Should Add Dr. Reddy's Stock to Your Portfolio
Zacks
Neutral
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma
Zacks
Neutral
Coherus BioSciences Reports Strong Q3 2024 Growth
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CHRS
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CHRS’s Media Buzz Sentiment?
Currently, no data Available
What is CHRS’s weekly average amount of articles?
Currently, no data Available
What is CHRS’s News Sentiment?
50% of articles about CHRS were positive this week, compared to its sector average of 64%.
    Healthcare Stocks that are Trending in the News
    LNTHLantheus
    INBSIntelligent Bio Solutions
    AKROAkero Therapeutics
    DVADaVita
    FNAParagon 28
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing